文献速递类风湿关节炎

短信强化监测与常规监测在早期类风湿关节炎中的随机对照试验

Automated Text Message-Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-01-01

该随机对照试验纳入166例早期未用过改善病情抗风湿药的类风湿关节炎患者,比较短信强化随访与常规随访对6个月Boolean缓解的影响。结果显示干预组6个月缓解率51%、对照组42%(P=0.34),未达主要终点,但干预组有获益趋势,可能与总体缓解率较高有关。

要点

  • 短信强化监测未显著提高6个月Boolean缓解率(51% vs 42%,P=0.34)。
  • 12个月缓解率干预组57%、对照组43%(P=0.17),差异无统计学意义。
  • 干预组46%报告药物问题、49%报告PtGA超过报警阈值。

核心结论

  • 短信强化监测未达到主要终点,但干预组缓解率有高于对照组的趋势。
  • 作者认为该结果可能归因于总体缓解率较高。

研究设计与样本

  • 随机对照试验,纳入166例早期、未使用过改善病情抗风湿药的类风湿关节炎患者。
  • 患者随机接受短信强化随访或常规随访,所有患者在0、3、6个月就诊,12个月随访。
  • 干预包括0-24周内13条短信,询问药物问题(是/否)和疾病活动度(PtGA,0-10分)。

主要发现

  • 干预组46%(38/82)报告药物问题,49%(40/82)报告短信PtGA超过报警阈值。
  • 6个月Boolean缓解率干预组51%、对照组42%(P=0.34);12个月分别为57%和43%(P=0.17)。
  • 6个月DAS28均值±SD干预组1.92±1.12、对照组2.22±1.11(P=0.09);12个月分别为1.79±0.91和2.08±1.22(P=0.28)。
  • 生活质量(SF-36)未观察到差异。

关键数值与推荐

  • 主要结局为6个月Boolean缓解,定义为无肿胀或压痛关节且C反应蛋白水平正常。
  • 短信报警阈值预先设定,PtGA超过阈值或报告药物问题时联系患者。

临床怎么用

  • 短信强化监测可作为早期类风湿关节炎的辅助随访工具,但本研究未证实其能显著改善缓解率。
  • 临床中可参考短信询问药物问题和PtGA来识别需要接触的患者。

局限性

  • 研究未达到主要终点,可能因总体缓解率较高而掩盖干预效果。
  • 6个月和12个月随访数据分别仅有162例和157例可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Frequent monitoring of patients with early rheumatoid arthritis (RA) is required for achieving good outcomes. This study was undertaken to investigate the influence of text message (SMS)-enhanced monitoring on early RA outcomes. METHODS: We randomized 166 patients with early, disease-modifying antirheumatic drug-naive RA to receive SMS-enhanced follow-up or routine care. All patients attended visits at 0, 3, and 6 months, and a follow-up visit at 12 months. Treatment was at the physicians' discretion. The intervention included 13 SMSs during weeks 0-24 with questions concerning medication problems (yes/no) and disease activity (patient global assessment [PtGA], scale 0-10). Patients were contacted if response SMSs indicated medication problems or PtGA exceeded predefined thresholds. Primary outcome was 6-month Boolean remission (no swollen or tender joints and normal C-reactive protein levels). Quality of life (QoL; measured by the Short Form 36 survey) and Disease Activity Score in 28 joints (DAS28) were assessed. RESULTS: Six and 12-month follow-up data were available for 162 and 157 patients, respectively. In the intervention group, 46% of the patients (38 of 82) reported medication problems and 49% (40 of 82) reported text message PtGAs above the alarm limit. Remission rates at 6 months (P = 0.34) were 51% in the intervention group and 42% in the control group. These rates were 57% and 43% at 12 months (P = 0.17) in the intervention and control groups, respectively. The respective mean ± SD DAS28 scores for the intervention and control groups were 1.92 ± 1.12 and 2.22 ± 1.11 at 6 months (P = 0.09); and 1.79 ± 0.91 and 2.08 ± 1.22 at 12 months (P = 0.28). No differences in QoL were observed. CONCLUSION: The study did not meet the primary outcome despite a trend favoring the intervention group. This may be explained by the notably high overall remission rates.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Kuusalo L, Sokka-Isler T, Kautiainen H, et al. Automated Text Message-Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial. Arthritis Care Res (Hoboken). 2020. PMID: 30740935. doi:10.1002/acr.23846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。